Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say
Starboards stake comes amid a time of struggle at the drugmaker, which has begun to cut costs aggressively as demand…
26,360$
2,29%
Echtzeit-Aktienkurs Pfizer Inc.
Bid:
Ask:
Nachrichten zur Pfizer Inc. Aktie
Activist Starboard Value Takes $1 Billion Stake in Pfizer
…
Activist Starboard takes $1B stake in Pfizer - WSJ
…
Activist investor Starboard Value takes $1 billion stake in Pfizer, sources say
…
Activist investor Starboard Value takes $1 billion stake in Pfizer, WSJ reports By Reuters
Activist investor Starboard Value takes $1 billion stake in Pfizer, WSJ reports…
Activist Investor Starboard Value Takes $1 Billion Stake in Pfizer, WSJ Reports
(Reuters) - Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the U.S. drug…
5 Large Drug Stocks to Watch From a Thriving Industry
Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), AstraZeneca (AZN),…
5 Things to Know Before the Stock Market Opens
Pfizer shares rise on report of activist investor stake, ExxonMobil stock adds to record highs as oil prices continue surge,…
Is Pfizer a Buy Right Now or a Value Trap?
Pfizer has prepared for todays challenges... and has set big goals.…
Is Pfizer a Buy Right Now or a Value Trap? @themotleyfool #stocks $PFE
Pfizer has prepared for todays challenges... and has set big goals.…
Zacks Investment Ideas feature highlights: Coca-Cola, Pfizer and Altria
Coca-Cola, Pfizer and Altria have been highlighted in this Investment Ideas article.…
Zacks Investment Ideas feature highlights: Coca-Cola, Pfizer and Altria
Coca-Cola, Pfizer and Altria have been highlighted in this Investment Ideas article.…
FIVE at FIVE: FTSE 100 up; Greggs results; Cold snap warning; Pfizer pares Haleon stake; Shop prices fall
1. FTSE 100 live UK blue chips outperform global market Read more 2. Greggs’ growth story shows signs of cooling…
Lock In A Phenomenal Yield With Pfizer
…
Haleon’s buy rating restated after Pfizer cuts down stake
UBS has reiterated its buy rating on Haleon PLC (LSE:HLN, NYSE:HLN) shares after news that former parent company Pfizer Inc…
Pfizer cuts Haleon stake in $3.3B share sale
…
Haleon PLC stock dips after Pfizers $3.26 bln stake sale By Investing.com
Haleon PLC stock dips after Pfizers $3.26 bln stake sale…
Haleon buys back some shares as Pfizer sells down stake
Haleon PLC (LSE:HLN, NYSE:HLN) said it has agreed to buy £230 million of its own shares from former co-parent Pfizer…
Pfizer offloads $3.3 billion stake in Sensodyne-maker Haleon By Reuters
Pfizer offloads $3.3 billion stake in Sensodyne-maker Haleon…
Pfizer: Growth From Oncology Franchise; Initiate With Buy
…
Zacks.com featured highlights include GIII Apparel Group, Sonoco Products, Hamilton Insurance Group, Pampa Energia S.A. and Pfizer
GIII Apparel Group, Sonoco Products, Hamilton Insurance Group, Pampa Energia S.A. and Pfizer are part of the Zacks Screen of…
Pfizer Aktie: Diese Nachricht sorgt für lange Gesichter
Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Pfizer Inc. (ISIN: US7170811035,…
Pfizer: 5,4 Milliarden Dollar in Luft aufgelöst
Diese Nachricht hat für lange Gesichter gesorgt - sowohl bei Kapitalmarktteilnehmern als auch betroffenen Patienten und darauf spezialisierten Medizinern. Pfizer…
Pfizer: 5,4 Milliarden Dollar in Luft aufgelöst
Diese Nachricht hat für lange Gesichter gesorgt – sowohl bei Kapitalmarktteilnehmern als auch betroffenen Patienten und darauf spezialisierten Medizinern. Pfizer…
Pfizer: 5,4 Milliarden Dollar in Luft aufgelöst
Diese Nachricht hat für lange Gesichter gesorgt – sowohl bei Kapitalmarktteilnehmern als auch betroffenen Patienten und darauf spezialisierten Medizinern. Pfizer…
Pfizer to Pare Back Haleon Stake With 540 Million Share Offering
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in…
Pfizer to offload about 5.9% stake in UKs Haleon, says bookrunner By Reuters
Pfizer to offload about 5.9% stake in UKs Haleon, says bookrunner…
Pfizer: A 6% Yielding Value Deal
…
Pfizers Strategie beginnt nach den Enttäuschungen rundum Sichelzellenanämie zu wackeln
Das Unternehmen gab bekannt, dass es Oxbryta, eine täglich einzunehmende Pille für Patienten mit Sichelzellenanämie, vom Markt nimmt Pfizers überraschende…
Jefferies senkt Ziel für Pfizer auf 33 Dollar - Buy
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Pfizer von 35 auf 33 US-Dollar gesenkt, aber…
Pharma Stock Roundup: JNJs 3rd Talc-Related Bankruptcy Filing & More
JNJ files for voluntary bankruptcy for the third time. Pfizer withdraws sickle-cell drug drug Oxbryta from worldwide markets.…
Aktienmarkt: Pfizer-Aktie tritt auf der Stelle (25,8094 €)
Der Kurs der dem Anteilsschein von Pfizer kommt kaum von der Stelle. Das Wertpapier notiert zur Stunde bei 28,84 US-Dollar.…
Pfizers Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say By Reuters
Pfizers Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say…
EU regulator recommends suspension of Pfizers sickle cell disease treatment By Reuters
EU regulator recommends suspension of Pfizers sickle cell disease treatment…
Slow progress on Pfizers plan to sell drugs to low-income nations at not-for-profit price, says CEO By Reuters
Slow progress on Pfizers plan to sell drugs to low-income nations at not-for-profit price, says CEO…
Pfizer Aktie: Rückzug von Oxbryta wirft Fragen zur Geschäftsentwicklung auf
London (www.aktiencheck.de) - Pfizer-Aktienanalyse von Barclays:
Aktuelle Bewertung
Carter Gould, Analyst von Barclays, behält eine "equal weight"-Bewertung für Pfizer Inc. (ISIN: US7170811035,…
Buy These 5 Big Drug Stocks to Boost Your Portfolios Health
Pfizer, Eli Lilly, AstraZeneca, Bayer and Sanofi can prove to be great additions to your portfolio.…
Pfizer Withdraws Sickle Cell Disease Therapy Oxbryta From Market
PFEs decision is based on clinical data, which suggests that the overall benefit of the drug no longer outweighs the…
Pfizer withdraws sickle cell disease treatment from all markets
U.S. drugmaker Pfizer said on Wednesday it is withdrawing its sickle cell disease therapy Oxbryta in all markets where it is approved…
Pfizer withdraws sickle cell drug Oxbryta over safety concerns
…
Pfizer withdraws sickle cell disease treatment from all markets By Reuters
Pfizer withdraws sickle cell disease treatment from all markets…
Pfizer: Undervalued Healthcare Leader Poised For Further Recovery
…
PFE & BNTX Get Positive CHMP Opinion for Updated COVID-19 Jab
The Committee for Medicinal Products for Human Use recommends marketing authorization for Pfizer and BioNTechs updated version of mRNA COVID-19…
Kursverluste für das Wertpapier von Pfizer (26,3052 €)
Der Anteilsschein von Pfizer notiert am Freitag leichter. Das Papier notiert aktuell bei 29,36 US-Dollar. Ein Minus von 1,03 Prozent…
Pfizer is a bottoming stock that will pay you to wait for the comeback, says Carter Worth
Cater Worth looks at the signs that Pfizer is starting to reverse the trend.…
Great investing debate: Growth or value stocks post-rate cuts?
Its an age-old question among investors: which is better, growth investing or value investing? After the Federal Reserves interest rate…
GNW-Adhoc: Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an Omikron KP.2 angepassten COVID-19-Impfstoff in der Europäischen Union
^* Der an Omikron KP.2 angepasste COVID-19-Impfstoff wird nach Zulassung durch die Europäische Kommission für Personen ab…
GNW-Adhoc: Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an Omikron KP.2 angepassten COVID-19-Impfstoff in der Europäischen Union
^* Der an Omikron KP.2 angepasste COVID-19-Impfstoff wird nach Zulassung durchdie Europäische Kommission für Personen ab 6 Monaten verfügbar sein*…
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
…
Jim Cramer on Pfizer Inc. (PFE): ‘The Answer Is Yes, Buy More’
We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to…